![(2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid structure](/static/products/897/897355-17-8.png)
(2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid
TL;DR: (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid (CAS 897355-17-8) is a chemical compound with molecular formula C16H22N4O4 and molecular weight 334.16 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
(E)-4-[[3-(cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]amino]-4-oxobut-2-enoic acid
Also Known As: (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid, (2E)-4-{[3-(cyclohexylcarbamoyl)-1-ethyl-1H-pyrazol-4-yl]amino}-4-oxobut-2-enoic acid, (E)-3-[[3-(cyclohexylcarbamoyl)-1-ethyl-pyrazol-4-yl]carbamoyl]prop-2-enoic Acid, (E)-4-((3-(cyclohexylcarbamoyl)-1-ethyl-1H-pyrazol-4-yl)amino)-4-oxobut-2-enoic acid, (E)-4-[[3-(cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]amino]-4-oxobut-2-enoic acid
| Molecular Formula | C16H22N4O4 |
|---|---|
| Molecular Weight | 334.16 g/mol |
| LogP | 1.5448 |
| Topological Polar Surface Area | 113.32 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Exact Mass | 334.1641 |
| Heavy Atoms | 24 |
| Complexity | 644.5026 |
Chemical Identifiers
| CAS Number | 897355-17-8 |
|---|---|
| SMILES | CCN1C=C(C(=N1)C(=O)NC2CCCCC2)NC(=O)/C=C/C(=O)O |
Product Overview
(2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid (CAS 897355-17-8), with molecular formula C16H22N4O4 and molecular weight 334.16 g/mol. IUPAC: (E)-4-[[3-(cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]amino]-4-oxobut-2-enoic acid.
Chemical Property Profile of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid
Property Insights of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid
The XLogP value of 1.5448 suggests moderate lipophilicity, balancing water solubility and membrane permeability for (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid. The TPSA of 113.32 Ų falls within the moderate polarity range, balancing permeability and solubility for (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid. Following Lipinski's Rule of Five, (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid has 3 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid?
The CAS number of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid is 897355-17-8.
What is the molecular formula of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid?
The molecular formula of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid is C16H22N4O4.
What is the molecular weight of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid?
The molecular weight of (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid is 334.16 g/mol.
Where can I buy (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid?
You can request a quote for (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid?
Yes, KEHONG BIO provides custom synthesis services for (2E)-3-{N-[3-(N-cyclohexylcarbamoyl)-1-ethylpyrazol-4-yl]carbamoyl}prop-2-enoi c acid and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.